PurpleLab
PrivateLast Round
Debt
Sep 24, 2025
Total Funding Raised
$64.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
PurpleLab operates in Healthcare & Life Sciences and is based in Wayne, Pennsylvania. Its latest recorded funding round was a Debt round in September 2025.
PurpleLab is a healthcare technology company that provides a no-code analytics platform, HealthNexus, which leverages real-world data to empower life sciences, payers, and providers with actionable insights.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Business Intelligence, Digital Advertising, Data Integration, Marketing
Business Model
B2B
Customer Profile
Subscription SaaS, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PurpleLab Comparables
Compare PurpleLab with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Flat Iron | 81% | |
| Komodo Health | 80% | |
| OMNY Health | 79% |
For institutional investors. Book with your work email.
PurpleLab Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Sep 24, 2025 | ||||
| Series B | Sep 12, 2022 | ||||
| Series A | Aug 8, 2019 | ||||
| Seed | Nov 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PurpleLab Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Edison Partners | Series B, Series A |
| M7holdings | Seed |
| Primus Capital Partners | Series B |
| Trinity Capital | Debt |
| M7 Holdings | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 10, 2026
PurpleLab has partnered with Throtle and Proximic by Comscore to enable new opportunities for healthcare buyers. The article provides no further details on the nature of the partnership.
- Mar 3, 2026
Aims to grow from 10 to over 20 customers by year-end.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- integrates_withSep 15, 2026
On Sep 18th '26 in New York, PurpleLab partners with Chalice Custom Algorithms, Inc to combine longitudinal medical and pharmacy claims data with custom AI modeling and optimization capabilities, enabling healthcare marketers to build predictive models for media decisions around business and patient outcomes.
For institutional investors. Book with your work email.
PurpleLab Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PurpleLab's valuation, stock price, and market status.
Is PurpleLab a public or private company?
PurpleLab is a private company.
What is the current stock price of PurpleLab?
PurpleLab is a private company, so its shares have no public market price. Caplight tracks PurpleLab's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PurpleLab worth (valuation)?
Valuation information for PurpleLab is not publicly available.
Can I buy PurpleLab stock?
PurpleLab shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PurpleLab's last funding round?
PurpleLab's most recent funding round was Debt on September 24, 2025.
Who are the main investors in PurpleLab?
Key investors in PurpleLab include Edison Partners, Primus Capital Partners, Trinity Capital.
Will PurpleLab IPO soon?
No public IPO plans have been announced for PurpleLab.
How can I track PurpleLab secondary market activity?
Caplight tracks bids, offers, and trades in PurpleLab's shares on secondary markets.